2100 Stock Overview
TECON BIOLOGY Co.LTD, together with its subsidiaries, engages in the provision of animal health care, feed, pig breeding, agricultural product processing and trade, and financial services in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
TECON BIOLOGY Co.LTD Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥6.51 |
| 52 Week High | CN¥9.50 |
| 52 Week Low | CN¥6.15 |
| Beta | 0.63 |
| 1 Month Change | -11.07% |
| 3 Month Change | -21.47% |
| 1 Year Change | -29.85% |
| 3 Year Change | -37.70% |
| 5 Year Change | -47.88% |
| Change since IPO | 215.73% |
Recent News & Updates
Shareholder Returns
| 2100 | CN Food | CN Market | |
|---|---|---|---|
| 7D | -9.8% | -2.5% | -0.2% |
| 1Y | -29.8% | -23.1% | -17.8% |
Return vs Industry: 002100 underperformed the CN Food industry which returned -25.2% over the past year.
Return vs Market: 002100 underperformed the CN Market which returned -21.1% over the past year.
Price Volatility
| 2100 volatility | |
|---|---|
| 2100 Average Weekly Movement | 6.5% |
| Food Industry Average Movement | 7.2% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 002100's share price has been volatile over the past 3 months.
Volatility Over Time: 002100's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 5,067 | Hui Cheng | www.tcsw.com.cn |
TECON BIOLOGY Co LTD, together with its subsidiaries, engages in the provision of animal health care, feed, pig breeding, agricultural product processing and trade, and financial services in China and internationally. The company operates through five divisions: Feed, Pharmaceutical, Food Farming, Protein Oil, and Agricultural Products.
TECON BIOLOGY Co.LTD Fundamentals Summary
| 2100 fundamental statistics | |
|---|---|
| Market cap | CN¥8.89b |
| Earnings (TTM) | -CN¥460.79m |
| Revenue (TTM) | CN¥18.55b |
0.5x
P/S Ratio-19.3x
P/E RatioIs 2100 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2100 income statement (TTM) | |
|---|---|
| Revenue | CN¥18.55b |
| Cost of Revenue | CN¥17.61b |
| Gross Profit | CN¥942.77m |
| Other Expenses | CN¥1.40b |
| Earnings | -CN¥460.79m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 29, 2024
| Earnings per share (EPS) | -0.34 |
| Gross Margin | 5.08% |
| Net Profit Margin | -2.48% |
| Debt/Equity Ratio | 58.6% |
How did 2100 perform over the long term?
See historical performance and comparison